Matches in Nanopublications for { ?s ?p "[In conclusion, our results point to COX-2 as a potential therapeutic target against obesity-associated metabolic dysfunction.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- assertion description "[In conclusion, our results point to COX-2 as a potential therapeutic target against obesity-associated metabolic dysfunction.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In conclusion, our results point to COX-2 as a potential therapeutic target against obesity-associated metabolic dysfunction.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In conclusion, our results point to COX-2 as a potential therapeutic target against obesity-associated metabolic dysfunction.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In conclusion, our results point to COX-2 as a potential therapeutic target against obesity-associated metabolic dysfunction.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1239739.RAD6MCC6-Nw4HCFKyEFxmEb6gqJNTBTptgOCEsvz-Q5W0130_assertion description "[In conclusion, our results point to COX-2 as a potential therapeutic target against obesity-associated metabolic dysfunction.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1239739.RAD6MCC6-Nw4HCFKyEFxmEb6gqJNTBTptgOCEsvz-Q5W0130_provenance.
- NP1239738.RAL7ACYXxg1iIhBO3cr5_DtuPiObTDErVV2hp3bBriaX4130_assertion description "[In conclusion, our results point to COX-2 as a potential therapeutic target against obesity-associated metabolic dysfunction.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1239738.RAL7ACYXxg1iIhBO3cr5_DtuPiObTDErVV2hp3bBriaX4130_provenance.